Lilly acquiring cancer-drug firm Ajax Therapeutics in deal worth up to $2.3B
The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.
Health Care & Life Sciences
Complex process leads to a new drug’s identity
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.
Central Indiana excelling in life sciences, but it needs a brand, speakers say
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.
Q&A: Cardiologist has spent career working on treatment for rare condition
Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley Children’s Health, has been working on a treatment for a neurodegenerative condition called Friedreich’s ataxia for decades.
IU, Zimmer Biomet forge 3-year partnership to advance orthopedic sector
The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.
Community Health Network Foundation names new CEO
Derek B. Groves will join Community Health Network Foundation in May as part of a planned leadership transition. He will succeed longtime CEO Joyce Irwin.
Ossium Health aims to revolutionize role of bone marrow banks
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
Greene County hospital serves Anthem with breach notice over underpayments
Hospital CEO Brenda Reetz the insurance underpayment situation impacts patient bills, hospital stability and access to care. Indianapolis-based Anthem said it is working with the hospital to resolve the problem.
Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies
Through the collaboration, Telix and Regeneron expect to develop and commercialize next-generation radiopharmaceutical therapies targeting cancer.
Corteva names CEO for ‘New Corteva’ crop protection spinoff
Luke Kissam will lead New Corteva after Corteva officially separates its pesticide and seed businesses into two independent, publicly traded companies.
Eli Lilly weight-loss pill Foundayo now available in United States
The Indianapolis-based drugmaker has started shipping the new pill to retail pharmacies.
Nearly $2B in funding for new Indianapolis VA hospital included in federal budget proposal
The budget proposal calls for a new 840,000-square-foot tower that would replace the aging Richard L. Roudebush Veterans Administration Medical Center.
IU researchers play role in development of new bladder cancer treatment
The treatment uses a combination of two drugs to battle the cancer in addition to surgery to remove tumors.
Boone County’s Witham Health Services plans to join Parkview Health
Witham’s announcement comes amid a series of recent moves by Parkview Health involving expansion into areas of the state away from its headquarters in Fort Wayne.
Bond trustee sues addiction treatment centers’ operator
Facilities in Greenfield and Knox are at the heart of a lawsuit that seeks to replace the centers’ Indianapolis-based operator, Crossroads Health Management LLC, over allegations of financial mismanagement and revenue diversion.
IU names board of nonprofit for real estate, research and life sciences work
Pamela Whitten, president of Indiana University, will serve as chair of the IU Inc. board of directors.
Construction on $4.3B IU Health hospital campus about 60% complete and on schedule
The 44-acre campus will span from 12th to 16th streets and from Capitol Avenue to Interstate 65 — approximately eight square blocks.
Lilly to acquire UK-based pharmaceutical company in deal worth up to $7.8B
Centessa Pharmaceuticals is developing treatments to address daytime sleepiness and other neurological conditions.
Lilly asks U.S. Supreme Court to rule part of False Claims Act unconstitutional
The Indianapolis-based drugmaker is challenging a $183.7 million judgment in a case brought by a pharmacist who alleged Lilly made false claims about rebates to the federal Medicaid program.
Obesity drug trials complicated by placebo patients leaving early
The companies developing new weight-loss medicines have a problem: People who don’t lose weight quickly figure out they were assigned to take a placebo and are bailing out of their clinical trials.